|
|
Volumn 306, Issue 17, 2011, Pages 1851-1852
|
|
FDA advisory decision highlights some problems inherent in pragmatic trials
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DABIGATRAN;
RIVAROXABAN;
WARFARIN;
CLINICAL STUDY;
CLINICAL TRIAL (TOPIC);
DRUG APPROVAL;
DRUG EFFICACY;
DRUG USE;
FOOD AND DRUG ADMINISTRATION;
HEART ATRIUM FIBRILLATION;
HUMAN;
PRIORITY JOURNAL;
RISK REDUCTION;
SHORT SURVEY;
STROKE;
|
|
EID: 80355129599
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2011.1570 Document Type: Short Survey |
|
Times cited : (5)
|
|
References (0)
|
